I personally believe in Slow Cattle, because there is a real lack of investment channels in China. Recently, the yield of government bonds has plummeted, the yield of Yu 'ebao has plummeted, and the interest on bank deposits has also plummeted. Where can money go? The stock market is a game of funds. Under such a loose monetary policy, the realization of A shares will not be bad. Everyone be patient, the long-term upward trend of our stock market will not change, and slow cattle and long cattle are worth looking forward to.Iii. 11 Linked Board Yiming Food: Shareholders reduced their holdings of 138,200 shares today, and there is a risk of a sharp decline in the short term.Wentai Technology: Shareholders plan to reduce their holdings by no more than 2%;
Shanghai's action plan for mergers and acquisitions is still very strong! Three years to cultivate 10 head companies, forming a scale of 300 billion mergers and acquisitions, which clearly accelerate the merger of securities companies and build a first-class investment bank. This is a semiconductor leader, a pharmaceutical leader, a new material leader, a brokerage leader, etc., which directly benefits Shanghai local stocks and pays attention to Shanghai's advantages. This time, the merger with assets exceeding 2 trillion is clearly activated, which shows great determination.First, heavy! Shanghai merger and reorganization action plan announcedIii. 11 Linked Board Yiming Food: Shareholders reduced their holdings of 138,200 shares today, and there is a risk of a sharp decline in the short term.
However, it is a great pity that the China stock market has never had a history of retail investors and institutions getting rich together. Don't deal with hot money and quantification! Foreign investment in A-shares has also become stale and has become fond of speculation. There are always too many routines to create A shares, which is too tiring to play, and the experience is really bad.Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.Wentai Technology: Shareholders plan to reduce their holdings by no more than 2%;
Strategy guide
12-14
Strategy guide 12-14